SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-22-197364
Filing Date
2022-07-20
Accepted
2022-07-20 06:08:29
Documents
1
Group Members
KAGOSHIMA DEVELOPMENT CO. LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d374827dsc13da.htm SC 13D/A 45390
  Complete submission text file 0001193125-22-197364.txt   47293
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Subject) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89180 | Film No.: 221092712
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6-1-20, NANEI KAGOSHIMA CITY KAGOSHIMA M0 891-0122
Business Address 6-1-20, NANEI KAGOSHIMA CITY KAGOSHIMA M0 891-0122 81-99-260-3311
Kagoshima Shinsangyo Sousei Investment Limited Partnership (Filed by) CIK: 0001657769 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 1231
Type: SC 13D/A